» Articles » PMID: 29040331

Primary Care Models for Treating Opioid Use Disorders: What Actually Works? A Systematic Review

Overview
Journal PLoS One
Date 2017 Oct 18
PMID 29040331
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Primary care-based models for Medication-Assisted Treatment (MAT) have been shown to reduce mortality for Opioid Use Disorder (OUD) and have equivalent efficacy to MAT in specialty substance treatment facilities.

Objective: The objective of this study is to systematically analyze current evidence-based, primary care OUD MAT interventions and identify program structures and processes associated with improved patient outcomes in order to guide future policy and implementation in primary care settings.

Data Sources: PubMed, EMBASE, CINAHL, and PsychInfo.

Methods: We included randomized controlled or quasi experimental trials and observational studies evaluating OUD treatment in primary care settings treating adult patient populations and assessed structural domains using an established systems engineering framework.

Results: We included 35 interventions (10 RCTs and 25 quasi-experimental interventions) that all tested MAT, buprenorphine or methadone, in primary care settings across 8 countries. Most included interventions used joint multi-disciplinary (specialty addiction services combined with primary care) and coordinated care by physician and non-physician provider delivery models to provide MAT. Despite large variability in reported patient outcomes, processes, and tasks/tools used, similar key design factors arose among successful programs including integrated clinical teams with support staff who were often advanced practice clinicians (nurses and pharmacists) as clinical care managers, incorporating patient "agreements," and using home inductions to make treatment more convenient for patients and providers.

Conclusions: The findings suggest that multidisciplinary and coordinated care delivery models are an effective strategy to implement OUD treatment and increase MAT access in primary care, but research directly comparing specific structures and processes of care models is still needed.

Citing Articles

Evaluation of a Program Designed to Support Implementation of Prescribing Medication for Treatment of Opioid Use Disorder in Primary Care Practices.

Hall T, Mendez D, Sobczak C, Mathieu S, Wiggins K, Cebuhar K Ann Fam Med. 2025; 23(1):44-51.

PMID: 39805692 PMC: 11772038. DOI: 10.1370/afm.3190.


Organization of primary care and early MOUD discontinuation.

Harris R, Kearney M, Keddem S, Calderbank T, Tomczuk L, Clapp J Addict Sci Clin Pract. 2024; 19(1):96.

PMID: 39702538 PMC: 11658460. DOI: 10.1186/s13722-024-00527-w.


Nurse Care Management of Opioid Use Disorder Treatment After 3 Years: A Secondary Analysis of the PROUD Cluster Randomized Clinical Trial.

Lapham G, Hyun N, Bobb J, Wartko P, Matthews A, Yu O JAMA Netw Open. 2024; 7(11):e2447447.

PMID: 39576637 PMC: 11584924. DOI: 10.1001/jamanetworkopen.2024.47447.


Substance abuse among new patients attending main government hospitals in Malaysia from 2018-2021: A comparison between before and during COVID-19 pandemic.

Muhamad N, Chemi N, Maamor N, Rosli I, Leman F, Mohamad Isa M PLoS One. 2024; 19(10):e0309422.

PMID: 39446726 PMC: 11500913. DOI: 10.1371/journal.pone.0309422.


Predicting buprenorphine adherence among patients with opioid use disorder in primary care settings.

Hooker S, Starkey C, Bart G, Rossom R, Kane S, Olson A BMC Prim Care. 2024; 25(1):361.

PMID: 39394565 PMC: 11468455. DOI: 10.1186/s12875-024-02609-9.


References
1.
Fiellin D, Weiss L, Botsko M, Egan J, Altice F, Bazerman L . Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone. J Acquir Immune Defic Syndr. 2011; 56 Suppl 1:S33-8. PMC: 3863630. DOI: 10.1097/QAI.0b013e3182097537. View

2.
Molfenter T, Sherbeck C, Zehner M, Quanbeck A, McCarty D, Kim J . Implementing buprenorphine in addiction treatment: payer and provider perspectives in Ohio. Subst Abuse Treat Prev Policy. 2015; 10:13. PMC: 4395880. DOI: 10.1186/s13011-015-0009-2. View

3.
Gunderson E, Wang X, Fiellin D, Bryan B, Levin F . Unobserved versus observed office buprenorphine/naloxone induction: a pilot randomized clinical trial. Addict Behav. 2010; 35(5):537-40. PMC: 2830372. DOI: 10.1016/j.addbeh.2010.01.001. View

4.
Holden R, Carayon P, Gurses A, Hoonakker P, Hundt A, Ozok A . SEIPS 2.0: a human factors framework for studying and improving the work of healthcare professionals and patients. Ergonomics. 2013; 56(11):1669-86. PMC: 3835697. DOI: 10.1080/00140139.2013.838643. View

5.
Eccles M, Grimshaw J, Campbell M, Ramsay C . Research designs for studies evaluating the effectiveness of change and improvement strategies. Qual Saf Health Care. 2003; 12(1):47-52. PMC: 1743658. DOI: 10.1136/qhc.12.1.47. View